Abeona Therapeutics Inc. Common Stock (ABEO)
PHARMACEUTICAL PREPARATIONS
Abeona Therapeutics Inc. Common Stock (ABEO) is listed on Nasdaq, where it has traded since September 19, 1980.
- Listed On
- Nasdaq
- Listed Since
- September 19, 1980
- Employees
- 226
- Market Cap
- $309M
About Abeona Therapeutics Inc. Common Stock
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 122 institutions reported holding ABEO, with 39.4 million shares worth $243.2 million in aggregate. The largest reported holder was Nantahala Capital Management, with 5.1 million shares worth $31.7 million. Of the 5 largest holders listed below, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Nantahala Capital Management | 5,136,490 | $32M | Added 2.46% |
| BlackRock | 3,352,474 | $21M | Added 4.91% |
| Cable Car Capital | 3,007,329 | $19M | Unchanged |
| Aigh Capital Management | 2,987,000 | $18M | Reduced 3.65% |
| Vanguard | 2,869,712 | $18M | Added 2.71% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ABEO?
Abeona Therapeutics Inc. Common Stock (ABEO) is listed on Nasdaq, where it has traded since September 19, 1980.
Who are the largest institutional holders of ABEO?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ABEO were Nantahala Capital Management, BlackRock and Cable Car Capital.
How many institutions own ABEO?
122 institutions reported a position in ABEO for the quarter ended June 30, 2026, worth $243.2 million in total.
Did institutions buy or sell ABEO last quarter?
Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for ABEO.
Every reported institutional holder, plus insider and congressional trades in ABEO, on SentiSense.